# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-19-008426
Filing Date
2019-05-30
Accepted
2019-05-30 16:05:39
Documents
3
Period of Report
2019-05-30
Effectiveness Date
2019-05-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | def14a.htm | DEF 14A | 192884
2 |  | proxyfront_001.jpg | GRAPHIC | 588506
3 |  | proxyback_002.jpg | GRAPHIC | 385425
| Complete submission text file | 0001493152-19-008426.txt |  | 1535353

Mailing Address 350 5TH AVENUE SUITE 4740 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 4740 NEW YORK NY 10118 212-330-8500
DAXOR CORP (Filer) CIK: 0000027367 (see all company filings)

EIN.: 132682108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 811-22684 | Film No.: 19866568
SIC: 3841 Surgical & Medical Instruments & Apparatus